These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37049427)

  • 1. Weekly Folic Acid Is a Convenient and Well-Tolerated Alternative to Daily Dosing in Pediatric Patients with Inflammatory Bowel Disease on Methotrexate.
    Temtem TA; Vickers M; Whitworth J
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
    Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E;
    Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with the use of low-dose methotrexate for inflammatory bowel disease.
    Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; Wang Y; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006618. PubMed ID: 25162749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose methotrexate in inflammatory bowel disease: current status and future directions.
    Schröder O; Stein J
    Am J Gastroenterol; 2003 Mar; 98(3):530-7. PubMed ID: 12650783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate for maintenance of remission in ulcerative colitis.
    Wang Y; MacDonald JK; Vandermeer B; Griffiths AM; El-Matary W
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007560. PubMed ID: 26263042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease.
    Heyman MB; Garnett EA; Shaikh N; Huen K; Jose FA; Harmatz P; Winter HS; Baldassano RN; Cohen SA; Gold BD; Kirschner BS; Ferry GD; Stege E; Holland N
    Am J Clin Nutr; 2009 Feb; 89(2):545-50. PubMed ID: 19116333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S; Noble A; Deslandres C
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Dupont-Lucas C; Grandjean-Blanchet C; Leduc B; Tripcovici M; Larocque C; Gervais F; Jantchou P; Amre D; Deslandres C
    Inflamm Bowel Dis; 2017 Feb; 23(2):298-303. PubMed ID: 28107279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oral administration of folic and folinic acid to prevent folate deficiency in patients with inflammatory bowel disease treated with salicylazosulfapyridine.
    Pironi L; Cornia GL; Ursitti MA; Dallasta MA; Miniero R; Fasano F; Miglioli M; Barbara L
    Int J Clin Pharmacol Res; 1988; 8(2):143-8. PubMed ID: 2897953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of methotrexate for treatment of inflammatory bowel disease in clinical practice.
    Saibeni S; Bollani S; Losco A; Michielan A; Sostegni R; Devani M; Lupinacci G; Pirola L; Cucino C; Meucci G; Basilisco G; D'Incà R; Bruno S
    Dig Liver Dis; 2012 Feb; 44(2):123-7. PubMed ID: 22051323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Folate Intake on Bone Mineral Density in Patients with Inflammatory Bowel Disease.
    Ratajczak-Pawłowska AE; Szymczak-Tomczak A; Michalak M; Rychter AM; Zawada A; Skoracka K; Dobrowolska A; Krela-Kaźmierczak I
    Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.
    Vandell AG; DiPiro JT
    Pharmacotherapy; 2002 May; 22(5):613-20. PubMed ID: 12013360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I; Faubion WA
    Inflamm Bowel Dis; 2012 Aug; 18(8):1488-92. PubMed ID: 21882301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate for inflammatory bowel disease: pharmacology and preliminary results.
    Egan LJ; Sandborn WJ
    Mayo Clin Proc; 1996 Jan; 71(1):69-80. PubMed ID: 8538238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.
    Kozarek RA; Patterson DJ; Gelfand MD; Botoman VA; Ball TJ; Wilske KR
    Ann Intern Med; 1989 Mar; 110(5):353-6. PubMed ID: 2492786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.